WebJan 2, 2001 · CSL Behring announced today the launch of a financial assistance program designed to cover patients’ out-of-pocket expenses for Berinert®, C1 Esterase Inhibitor (Human), a pasteurized, nanofiltered therapy indicated for the treatment of acute laryngeal, facial and abdominal attacks of hereditary angioedema (HAE).HAE is a rare and … WebAbout CSL Behring CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
Support and Resources BERINERT C1 Esterase Inhibitor, Human
WebHAEGARDA is indicated for patients 6 years of age and older. This means your loved one can live a full, happy life with HAE from childhood through adult years. You may be concerned about how having HAE will affect your loved one's life and your life. Many people find they can help successfully manage their loved one's condition by working with ... WebCall 866-415-2164 to speak to a CSL Behring Assurance Program Case Manager. You will be notified of your enrollment status when the CSL Behring Assurance Program … sinatra smith so in love
CSL Behring Launches Its First Co-Pay Assistance Program to …
WebResources are available to help your eligible patients get the treatment they need for hemophilia B, including: A free trial of IDELVION; Co-pay assistance ‡ Lapse-in-coverage support with the CSL Behring … WebCSL Behring Assurance SM Program Protection against a lapse in coverage: The CSL Behring Assurance Program can help make product available to eligible patients … WebCSL Behring / MMR Consulting. Oct 2024 - Present7 months. Illinois, United States. - Eliminated backlog of overdue investigations and CAPAs. - Investigations management: monitoring due dates ... sinatra one more for the road